TenK10K maps 5 million immune cells, linking DNA variants to 16 diseases
An Australian-led team built the most detailed map yet of how DNA variants steer immune activity, using single-cell sequencing on nearly 5 million immune cells and the genomes of about 2,000 people. Three studies in Nature tie those variants to 16 autoimmune, neurological and oncological diseases. One variant in natural killer cells points to an unknown route to irritable bowel syndrome. Read more on Paparazzi. Follow for more.
- Original source: fnob.it.
- The source published it on Nov 19, 2026 at 9:00 AM.
- No second outlet has reported it yet. Treat it as a single-source claim.
Researchers mapped nearly 5 million immune cells and the genomes of about 2,000 people across three studies published at the same time in Nature. The work, known as the TenK10K project, was led by the Garvan Institute of Medical Research with other Australian centers, and it links DNA variants to 16 diseases spanning autoimmune, neurological and oncological conditions. According to Agenbio, it is the most detailed map yet of how genetic variants shape immune activity.
The breakthrough came from single-cell sequencing. Rather than measuring gene expression across mixed cell populations, the team resolved gene activity one cell at a time. That shift exposed nearly 1,500 genes that contribute to the diseases studied but act only inside specific cell types, making them invisible to conventional methods.
The project traced a full chain: from a genetic variant to the cell type it affects, then to the molecular mechanism, and finally to disease risk. One example stands out. A variant that raises expression of the OSM gene in natural killer cells was tied to a higher risk of irritable bowel syndrome, pointing to an immune pathway that had not been recognized before and could potentially be targeted by drugs.
The stated goal is clinical. Researchers want to use the data to spot, in advance, which patients are most likely to respond to specific therapies based on their genetic and cellular profiles. The findings, published by the Garvan Institute-led team, arrive as three separate papers in Nature.
TopicsGarvan Institute of Medical Research · TenK10K · Nature · OSM gene · natural killer cells · irritable bowel syndrome
Source: fnob.it
Written by AI from verified reporting.
More stories
- Health & science finance.yahoo.com 0 viewsSanofi's next-gen rabies shot VaxRabeo scores EU approval
- Health & science reuters.com Caught by @mimi💕💕 1 viewAbbVie Bets Up to $2.54B on Disco's Next-Gen Cancer Drugs
- Health & science trtworld.com Caught by @pz09253 0 viewsFrance lifts bird flu alert to maximum level across mainland
- Health & science news24.com.au 0 viewsActinogen trial: Alzheimer's drug slows decline by 30pc in over-75s

